Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Covington
Farmers Insurance
Colorcon
Harvard Business School
Chinese Patent Office
Dow
Medtronic
Baxter

Generated: December 9, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR AMBIEN

« Back to Dashboard

Clinical Trials for Ambien

Trial ID Title Status Sponsor Phase Summary
NCT00042146 Behavioral and Pharmacological Treatment for Insomnia Completed National Institute of Mental Health (NIMH) Phase 4 This study will evaluate the long- and short-term effects of cognitive-behavior therapy (CBT), alone and in combination with zolpidem (Ambien®), for chronic insomnia.
NCT00042146 Behavioral and Pharmacological Treatment for Insomnia Completed Laval University Phase 4 This study will evaluate the long- and short-term effects of cognitive-behavior therapy (CBT), alone and in combination with zolpidem (Ambien®), for chronic insomnia.
NCT00044629 Combined Behavioral/Pharmacological Therapy for Insomnia Completed National Institute of Mental Health (NIMH) Phase 2 This study will determine how sleeping pills can be combined with nondrug treatments to maximize the benefits of therapy for insomnia.
NCT00044629 Combined Behavioral/Pharmacological Therapy for Insomnia Completed Duke University Phase 2 This study will determine how sleeping pills can be combined with nondrug treatments to maximize the benefits of therapy for insomnia.
NCT00086281 Trial of Effects of Oral Xyrem and Zolpidem on Sleep-Disordered Breathing in Obstructive Sleep Apnea Patients Completed Jazz Pharmaceuticals Phase 4 To study the effect of Xyrem (9 g), Xyrem (9 g) plus modafinil 200 mg administered the morning prior to Xyrem, positive control (zolpidem 10 mg), and placebo on the frequency and outcome of events of sleep-disordered breathing in patients with obstructive sleep apnea syndrome (OSAS).
NCT00156533 Long Term Treatment With Zolpidem: Nightly and Intermittent Dosing Completed Sanofi-Synthelabo Phase 4 We want to assess whether "how and when" one takes sleep medication results in similar or different outcomes with respect to symptom relief. We also want to know whether taking medication for a period of time provides continued benefit once the medication is stopped.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Ambien

Condition Name

Condition Name for Ambien
Intervention Trials
Healthy 9
Insomnia 8
Sleep Initiation and Maintenance Disorders 4
Sleep Disorders 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Ambien
Intervention Trials
Sleep Initiation and Maintenance Disorders 16
Depression 4
Sleep Wake Disorders 3
Parasomnias 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Ambien

Trials by Country

Trials by Country for Ambien
Location Trials
United States 80
Canada 7
Germany 4
United Kingdom 4
Italy 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Ambien
Location Trials
California 7
Pennsylvania 7
New York 7
Massachusetts 6
Ohio 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Ambien

Clinical Trial Phase

Clinical Trial Phase for Ambien
Clinical Trial Phase Trials
Phase 4 14
Phase 3 3
Phase 2/Phase 3 2
[disabled in preview] 12
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Ambien
Clinical Trial Phase Trials
Completed 31
Recruiting 5
Active, not recruiting 3
[disabled in preview] 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Ambien

Sponsor Name

Sponsor Name for Ambien
Sponsor Trials
National Institute of Mental Health (NIMH) 6
Sanofi 5
Mclean Hospital 3
[disabled in preview] 6
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Ambien
Sponsor Trials
Other 26
Industry 24
NIH 10
[disabled in preview] 10
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Farmers Insurance
Covington
Baxter
Medtronic
Harvard Business School
Fish and Richardson
Daiichi Sankyo
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.